A phase II trial of ORY-2001 in Alzheimer's disease patients

Trial Profile

A phase II trial of ORY-2001 in Alzheimer's disease patients

Planning
Phase of Trial: Phase II

Latest Information Update: 25 Jan 2017

At a glance

  • Drugs ORY 2001 (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jan 2017 According to Oryzon media release, this trial is expected to proceed in 2H of 2017.
    • 06 Apr 2016 New trial record
    • 04 Apr 2016 According to an Oryzon Genomics media release, the company plans to initiate this trial in 1H 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top